prikaz prve stranice dokumenta Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
  Preuzmi
PDF 614.83 KB
Znanstveni rad - Izvorni znanstveni rad
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
Acta clinica Croatica, 60. (2021), Supplement 2; 36-52. https://doi.org/10.20471/acc.2021.60.s1.03
Virović Jukić, Lucija; Grgurević, Ivica; Mikolašević, Ivana; Filipec Kanižaj, Tajana; Milić, Sandra; Mrzljak, Anna; Premužić, Marina; Hrstić, Irena; Knežević Štromar, Ivana; Ljubičić, Neven; Ostojić, Rajko; Stojsavljević Shapeski, Sanja; Amerl-Šakić, Vjekoslava; Bašić Marković, Nina; Rađa, Marko; Soldo, Dragan; Sobočan, Nikola; Lalovac, Miloš; Puljiz, Željko; Podrug, Kristian; Ladić, Dinko Više autora...

Citirajte ovaj rad

Virović Jukić, L., Grgurević, I., Mikolašević, I., Filipec Kanižaj, T., Milić, S., Mrzljak, A. ... Ladić, D. (2021). Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease. Acta clinica Croatica, 60.. (Supplement 2), 36-52. doi: 10.20471/acc.2021.60.s1.03

Virović Jukić, Lucija, et al. "Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease." Acta clinica Croatica, vol. 60., br. Supplement 2, 2021, str. 36-52. https://doi.org/10.20471/acc.2021.60.s1.03

Virović Jukić, Lucija, Ivica Grgurević, Ivana Mikolašević, Tajana Filipec Kanižaj, Sandra Milić, Anna Mrzljak, Marina Premužić, et al. "Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease." Acta clinica Croatica 60., br. Supplement 2 (2021): 36-52. https://doi.org/10.20471/acc.2021.60.s1.03

Virović Jukić, L., et al. (2021) 'Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease', Acta clinica Croatica, 60.(Supplement 2), str. 36-52. doi: 10.20471/acc.2021.60.s1.03

Virović Jukić L, Grgurević I, Mikolašević I, Filipec Kanižaj T, Milić S, Mrzljak A, i sur.. Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease. Acta clinica Croatica [Internet]. 2021. [pristupljeno 14.11.2024.];60.(Supplement 2):36-52. doi: 10.20471/acc.2021.60.s1.03

L. Virović Jukić, et al., "Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease", Acta clinica Croatica, vol. 60., br. Supplement 2, str. 36-52, 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:119870. [Citirano: 14.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:119870
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
AutorLucija Virović Jukić
AutorIvica Grgurević
AutorIvana Mikolašević
AutorTajana Filipec Kanižaj
AutorSandra Milić
AutorAnna Mrzljak
AutorMarina Premužić
AutorIrena Hrstić
AutorIvana Knežević Štromar
AutorNeven Ljubičić
AutorRajko Ostojić
AutorSanja Stojsavljević Shapeski
AutorVjekoslava Amerl-Šakić
AutorNina Bašić Marković
AutorMarko Rađa
AutorDragan Soldo
AutorNikola Sobočan
AutorMiloš Lalovac
AutorŽeljko Puljiz
AutorKristian Podrug
AutorDinko Ladić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Nonalcoholic fatty liver disease (NAFLD) is a term describing excessive accumulation of fat in hepatocytes, and is associated with metabolic syndrome and insulin resistance. NAFLD prevalence is on increase and goes in parallel with the increasing prevalence of metabolic syndrome and its components. That is why Croatian guidelines have been developed, which cover the screening protocol for patients with NAFLD risk factors, and the recommended diagnostic work-up and treatment of NAFLD patients. NAFLD screening should be done in patients with type 2 diabetes mellitus, or persons with two or more risk factors as part of metabolic screening, and is carried out by noninvasive laboratory and imaging methods used to detect fibrosis. Patient work-up should exclude the existence of other causes of liver injury and determine the stage of fibrosis as the most important factor in disease prognosis. Patients with initial stages of fibrosis continue to be monitored at the primary healthcare level with the management of metabolic risk factors, dietary measures, and increased physical activity. Patients with advanced fibrosis should be referred to a gastroenterologist/ hepatologist for further treatment, monitoring, and detection and management of complications.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaActa clinica Croatica
Brojčani podacivol. 60., br. Supplement 2, str. 36-52
p-ISSN0353-9466
e-ISSN1333-9451
DOIhttps://doi.org/10.20471/acc.2021.60.s1.03
URN:NBNurn:nbn:hr:184:119870
Datum objave publikacije2021
URL dokumentahttps://hrcak.srce.hr/275610
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-04-27 11:08:41